Table 1.

Phenotypes of IELs in the control group and the treatment group (%)

Cell population	Control group	Treatment group
		Day 9	Day 35	Day 70
CD8+CD4−	68.83 ± 1.76	70.03 ± 2.35	83.9 ± 0.81*	67.94 ± 1.88
CD8−CD4+	28.59 ± 1.52	27.54 ± 6.44	27.91 ± 3.13	28.33 ± 3.19
TCR αβ+	23.37 ± 4.59	54.15 ± 5.19*	35.96 ± 2.24*	23.82 ± 2.09
TCR γδ+	11.05 ± 1.66	5.61 ± 0.35*	7.54 ± 0.86*	10.56 ± 0.54
CD20+†	6.59 ± 1.12	1.58 ± 0.40*	2.23 ± 1.18*	6.53 ± 1.22

Data are presented as the percentage of cells with respect to the total number of CD3⁺ cells; n = 3 per group. *P < 0.05 versus the control group; ^†The value is the percentage of CD3⁻ CD20⁺ cells. TCR: T-cell receptor; IELs: Intestinal intraepithelial lymphocytes.